ID20967A - Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut - Google Patents

Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut

Info

Publication number
ID20967A
ID20967A IDP981279A ID981279A ID20967A ID 20967 A ID20967 A ID 20967A ID P981279 A IDP981279 A ID P981279A ID 981279 A ID981279 A ID 981279A ID 20967 A ID20967 A ID 20967A
Authority
ID
Indonesia
Prior art keywords
christants
medicine
contain
making
materials
Prior art date
Application number
IDP981279A
Other languages
English (en)
Indonesian (id)
Inventor
Joachim Dr Brendel
Uwe Dr Gerlach
Hans Jochen Dr Lang
Klaus Dr Weidmann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ID20967A publication Critical patent/ID20967A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
IDP981279A 1997-09-26 1998-09-24 Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut ID20967A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742508A DE19742508A1 (de) 1997-09-26 1997-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
ID20967A true ID20967A (id) 1999-04-01

Family

ID=7843708

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981279A ID20967A (id) 1997-09-26 1998-09-24 Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut

Country Status (25)

Country Link
US (1) US6177449B1 (fr)
EP (1) EP0906911B1 (fr)
JP (1) JP4422222B2 (fr)
KR (1) KR19990030120A (fr)
CN (1) CN1216763A (fr)
AR (1) AR014915A1 (fr)
AT (1) ATE265445T1 (fr)
AU (1) AU755735B2 (fr)
BR (1) BR9803367A (fr)
CA (1) CA2248300C (fr)
CZ (1) CZ307198A3 (fr)
DE (2) DE19742508A1 (fr)
ES (1) ES2221107T3 (fr)
HR (1) HRP980528A2 (fr)
HU (1) HUP9802155A3 (fr)
ID (1) ID20967A (fr)
IL (1) IL126280A (fr)
NO (1) NO984476L (fr)
NZ (1) NZ332030A (fr)
PL (1) PL328854A1 (fr)
RU (1) RU2220965C2 (fr)
SK (1) SK131898A3 (fr)
TR (1) TR199801903A2 (fr)
TW (1) TW565559B (fr)
ZA (1) ZA988788B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
FI20011507A0 (fi) * 2001-07-10 2001-07-10 Orion Corp Uusia yhdisteitä
US7001660B2 (en) * 2001-07-16 2006-02-21 Gilbert Garitano Images in solids surfaces
FI20030030A0 (fi) * 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1871758B1 (fr) * 2005-04-12 2010-08-25 Abbott Products GmbH Derives de 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2h-cromen-6-yle aminoalkyl-amidomethyl-substitutes et leur utilisation comme bloqueurs des canaux potassiques
US7714150B2 (en) 2005-04-12 2010-05-11 Solvay Pharmaceuticals Gmbh Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
FR2639349B1 (fr) 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5428031A (en) 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
AU711986B2 (en) * 1996-05-15 1999-10-28 Hoechst Aktiengesellschaft Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
TR199801903A3 (tr) 1999-04-21
KR19990030120A (ko) 1999-04-26
CA2248300A1 (fr) 1999-03-26
JPH11158171A (ja) 1999-06-15
RU2220965C2 (ru) 2004-01-10
HUP9802155A2 (hu) 1999-09-28
AU755735B2 (en) 2002-12-19
US6177449B1 (en) 2001-01-23
BR9803367A (pt) 2000-05-09
TR199801903A2 (xx) 1999-04-21
TW565559B (en) 2003-12-11
AU8708298A (en) 1999-04-15
EP0906911A1 (fr) 1999-04-07
SK131898A3 (en) 1999-06-11
CA2248300C (fr) 2008-12-02
DE59811267D1 (de) 2004-06-03
NZ332030A (en) 2000-04-28
HUP9802155A3 (en) 2002-04-29
NO984476D0 (no) 1998-09-25
CN1216763A (zh) 1999-05-19
ZA988788B (en) 1999-03-26
NO984476L (no) 1999-03-29
HU9802155D0 (en) 1998-11-30
DE19742508A1 (de) 1999-04-01
ATE265445T1 (de) 2004-05-15
HRP980528A2 (en) 1999-06-30
AR014915A1 (es) 2001-04-11
PL328854A1 (en) 1999-03-29
CZ307198A3 (cs) 1999-04-14
IL126280A0 (en) 1999-05-09
EP0906911B1 (fr) 2004-04-28
IL126280A (en) 2003-10-31
ES2221107T3 (es) 2004-12-16
JP4422222B2 (ja) 2010-02-24

Similar Documents

Publication Publication Date Title
ID26876A (id) Derivat-derivat benzotiepin 1,1-dioksida, proses pembuatannya, bahan-bahan farmasi yang terdiri dari senyawa-senyawa ini dan penggunaannya
ID26399A (id) Turunan 1-(1-tersubstitusi-4-piperidinil) metil -4-piperidin, proses pembuatannya, komposisi farmasi yang mengandung senyawa tersebut, dan intermedietnya
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
ID22528A (id) Komposisi farmasi fenofibrat yang memiliki biovabilitas tinggi dan metoda pembuatannya
ID26420A (id) Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID18613A (id) Oksadiazol baru, proses pembuatannya serta penggunaannya sebagai komposisi farmasi
HUP0001153A3 (en) Chemically modified polypeptides, process for producing thereof, pharmaceutical compositions comprising these polypeptides and their use
NO982302D0 (no) Farmas÷ytisk sammensetning
ID19574A (id) Lingkar-lingkar aneka beranggota-5 yang mempunyai substitusi bifenilsulfonil, proses pembuatannya penggunaannya sebagai obat atau diagnosa dan obat yang terdiri dari zat-zat itu
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID25516A (id) Senyawa-senyawa yang mengandung cincin-cincin beranggotakan enam, proses pembuatannya, dan penggunaannya sebagai obat
ID27558A (id) Amida-amida aromatik baru, metode pembuatannya dan penggunaannya sebagai obat
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
ID17810A (id) Turunan-turunan 2,4-tiazolidindion tersubstitusi baru, proses untuk pembuatannya dan komposisi farmasi yang mengandungnya
ID20604A (id) Polisakarida sintetis proses untuk pembuatan dan komposisi farmasi yang dikandungnya
ID20855A (id) Senyawa turunan imidazolidin baru, pembuatannya, penggunaannya dan sediaan farmasi yang mengandung senyawa tersebut
ID22911A (id) Turunan-turunan triazol baru, proses pembuatan dan komposisi-komposisi farmasi yang mengandungnya
ID20967A (id) Kroman tersubstitusi sulfonamida, proses pembuatannya, penggunaannya sebagai obat, dan sediaan farmasi yang mengandung bahan tersebut
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID18817A (id) 3-amidokromanilsulfonil (tio) urea, proses untuk pembuatan, penggunaan, dan sediaan-sediaan farmasi yang mengandungnya
ID16989A (id) 2-naftoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya